-
Something wrong with this record ?
Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
O. Schnell, E. Standl, D. Catrinoiu, S. Genovese, N. Lalic, J. Skra, P. Valensi, D. Rahelic, A. Ceriello,
Language English Country Great Britain
Document type Congress, Editorial
NLK
BioMedCentral
from 2002-12-01
BioMedCentral Open Access
from 2002
Directory of Open Access Journals
from 2002
Free Medical Journals
from 2002
PubMed Central
from 2002
Europe PubMed Central
from 2002
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2002-01-01
Open Access Digital Library
from 2002-04-01
Open Access Digital Library
from 2002-01-01
Medline Complete (EBSCOhost)
from 2002-04-08
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2002
Springer Nature OA/Free Journals
from 2002-12-01
- MeSH
- Diabetes Mellitus, Type 2 complications drug therapy economics mortality MeSH
- Risk Assessment MeSH
- Hypoglycemic Agents adverse effects economics therapeutic use MeSH
- Cardiovascular Diseases economics etiology mortality prevention & control MeSH
- Clinical Trials as Topic MeSH
- Humans MeSH
- Evidence-Based Medicine MeSH
- Drug Costs MeSH
- Protective Factors MeSH
- Risk Factors MeSH
- Insurance, Health, Reimbursement MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Congress MeSH
- Editorial MeSH
The 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group was held on the 20th-21st October 2016 in Munich. This second Summit was organized in light of recently published CVOTs on diabetes, with the aim of serving as a reference meeting for discussion on this topic. Along with presentations on the results of the most recently published CVOTs, panel discussions on trial implications for reimbursement and the perspective of cardiologists and/or nephrologists, as well as on CVOTs weaknesses and potentials constituted the heart of the program. Future activities of the D&CVD EASD Study Group in 2017 include an annual meeting in Milano and the 3rd CVOT Summit on Diabetes of the D&CVD EASD Study Group, in Munich ( http://www.dcvd.org ).
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016730
- 003
- CZ-PrNML
- 005
- 20180517110543.0
- 007
- ta
- 008
- 180515s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12933-017-0508-8 $2 doi
- 035 __
- $a (PubMed)28284218
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Schnell, Oliver $u Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, 85764, Neuherberg, Germany. oliver.schnell@lrz.uni-muenchen.de.
- 245 10
- $a Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group / $c O. Schnell, E. Standl, D. Catrinoiu, S. Genovese, N. Lalic, J. Skra, P. Valensi, D. Rahelic, A. Ceriello,
- 520 9_
- $a The 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group was held on the 20th-21st October 2016 in Munich. This second Summit was organized in light of recently published CVOTs on diabetes, with the aim of serving as a reference meeting for discussion on this topic. Along with presentations on the results of the most recently published CVOTs, panel discussions on trial implications for reimbursement and the perspective of cardiologists and/or nephrologists, as well as on CVOTs weaknesses and potentials constituted the heart of the program. Future activities of the D&CVD EASD Study Group in 2017 include an annual meeting in Milano and the 3rd CVOT Summit on Diabetes of the D&CVD EASD Study Group, in Munich ( http://www.dcvd.org ).
- 650 _2
- $a kardiovaskulární nemoci $x ekonomika $x etiologie $x mortalita $x prevence a kontrola $7 D002318
- 650 _2
- $a klinické zkoušky jako téma $7 D002986
- 650 _2
- $a diabetes mellitus 2. typu $x komplikace $x farmakoterapie $x ekonomika $x mortalita $7 D003924
- 650 _2
- $a náklady na léky $7 D016527
- 650 _2
- $a medicína založená na důkazech $7 D019317
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoglykemika $x škodlivé účinky $x ekonomika $x terapeutické užití $7 D007004
- 650 _2
- $a úhrada zdravotního pojištění $7 D007349
- 650 _2
- $a ochranné faktory $7 D065840
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a kongresy $7 D016423
- 655 _2
- $a úvodníky $7 D016421
- 700 1_
- $a Standl, Eberhard $u Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, 85764, Neuherberg, Germany.
- 700 1_
- $a Catrinoiu, Doina $u Internal Medicine Department, Clinical County Emergency Hospital Constanta, Tomis Blvd, No. 145, 900591, Constanta, Romania.
- 700 1_
- $a Genovese, Stefano $u Diabetes and Metabolic Disease Unit, IRCCS MultiMedica, Via Milanese 300, 20099, Sesto San Giovanni, MI, Italy.
- 700 1_
- $a Lalic, Nebojsa $u Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr Subotica 13, Belgrade, 11000, Serbia.
- 700 1_
- $a Skra, Jan $u 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, U Nemocnice 1, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Valensi, Paul $u Department of Endocrinology Diabetology Nutrition, CINFO, CRNH-IdF, Jean VERDIER Hospital, Paris 13 University, Avenue du 14 Juillet, 93140, Bondy, France.
- 700 1_
- $a Rahelic, Dario $u Diabetes and Metabolic Disorders, Dubrava University Hospital, Avenija Gojka Šuška 6, 10000, Zagreb, Croatia.
- 700 1_
- $a Ceriello, Antonio $u Diabetes and Metabolic Disease Unit, IRCCS MultiMedica, Via Milanese 300, 20099, Sesto San Giovanni, MI, Italy.
- 773 0_
- $w MED00008211 $t Cardiovascular diabetology $x 1475-2840 $g Roč. 16, č. 1 (2017), s. 35
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28284218 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180517110720 $b ABA008
- 999 __
- $a ok $b bmc $g 1300354 $s 1013570
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 16 $c 1 $d 35 $e 20170311 $i 1475-2840 $m Cardiovascular diabetology $n Cardiovasc Diabetol $x MED00008211
- LZP __
- $a Pubmed-20180515